Treatment for bronchiolitis in adults depends almost entirely on what type of bronchiolitis you have, because “bronchiolitis” is not one disease but a family of conditions that all share inflammation of the small airways. Acute viral bronchiolitis gets supportive care. Diffuse panbronchiolitis responds remarkably well to low-dose macrolide antibiotics. Organizing pneumonia usually requires months of corticosteroids. Constrictive bronchiolitis after a transplant demands an entirely different strategy. Identifying the subtype is the first and most consequential step, and that is where adult bronchiolitis gets tricky: the clinical presentation is far less predictable than it is in infants, and misdiagnosis is common.
Why Adult Bronchiolitis Is Harder to Pin Down
Most people associate bronchiolitis with babies who wheeze through winter RSV season, and for good reason. But in adults the same small-airway inflammation can be triggered by a wide range of causes: viruses like RSV, influenza, adenovirus, and parainfluenza; bacteria like Mycoplasma pneumoniae; autoimmune diseases such as rheumatoid arthritis; organ transplantation; toxic fume inhalation; certain medications; and even smoking itself.1Clinical Research Trials. Bronchiolitis in adult: A review Unlike childhood bronchiolitis, which follows a fairly recognizable pattern of cough, wheeze, and respiratory distress during viral season, adult bronchiolitis can look like asthma, COPD, pneumonia, or even heart failure on an initial evaluation. That overlap means the condition often goes unrecognized or gets treated with the wrong drugs for weeks before the real diagnosis surfaces.
Getting the Diagnosis Right
A plain chest X-ray can look nearly normal in many forms of adult bronchiolitis, which is one reason it slips past initial workups. High-resolution computed tomography, or HRCT, is the imaging tool that makes the difference. HRCT can pick up the hallmark findings: tiny centrilobular nodules sitting in the center of secondary lung lobules, ground-glass opacities, and the distinctive “tree-in-bud” pattern, which looks like branching structures radiating from a small airway.2European Society of Radiology. Bronchiolitis: A Practical Approach for the General Radiologist These findings help radiologists and pulmonologists narrow down the subtype. A tree-in-bud pattern with solid nodules, for instance, suggests an infectious or aspirational cause, while mosaic attenuation and air trapping on expiratory images point toward constrictive bronchiolitis. In some cases, a lung biopsy is still necessary for a definitive answer, particularly when the imaging pattern is ambiguous or the patient is not responding to initial treatment.
Pulmonary function tests add another layer. Most forms of bronchiolitis produce an obstructive pattern on spirometry, meaning airflow out of the lungs is restricted. But organizing pneumonia, a related small-airway condition, often shows a restrictive pattern instead. Matching the imaging findings, spirometry results, clinical history, and sometimes biopsy pathology is what ultimately points toward the right treatment.
Acute Infectious Bronchiolitis
When a virus or bacterium directly inflames the small airways, the resulting illness is acute infectious bronchiolitis. In adults, the most common culprits are RSV, cytomegalovirus, adenovirus, influenza, parainfluenza, rhinovirus, human metapneumovirus, and varicella zoster.3Karger. Bronchiolitis in Adults: Etiology, Diagnostic, and Therapeutic Approach The treatment is largely supportive: fluids, supplemental oxygen if oxygen levels dip, rest, and in severe cases nutrition support through tube feeding. If a bacterial agent such as Mycoplasma is identified, targeted antibiotics are appropriate.
Bronchodilators like albuterol and inhaled corticosteroids are frequently tried because the wheezing can mimic asthma. The evidence, however, shows that neither bronchodilators nor inhaled steroids change meaningful outcomes such as length of illness or need for hospitalization. Some patients report subjective relief from bronchodilators, which is why clinicians sometimes prescribe a trial, but expectations should be realistic.3Karger. Bronchiolitis in Adults: Etiology, Diagnostic, and Therapeutic Approach Ribavirin, an antiviral, has a narrow role: it may help immunocompromised patients, particularly those with blood cancers, though a meta-analysis found the benefit was largely limited to that specific group.
For otherwise healthy adults who develop acute infectious bronchiolitis, the illness usually resolves on its own over a few weeks, much as a bad chest cold would. The lingering cough can persist for several weeks beyond the acute phase. People with weakened immune systems, those on chemotherapy, or organ transplant recipients face a more serious course and may require hospitalization.
Diffuse Panbronchiolitis and Macrolide Therapy
Diffuse panbronchiolitis is a chronic inflammatory condition that affects airways throughout both lungs and was historically most recognized in East Asian populations. Before effective treatment was discovered, the prognosis was grim. The breakthrough came with low-dose macrolide antibiotics, and it remains one of the clearest success stories in pulmonary medicine.
Azithromycin, given at doses far lower than those used to fight bacterial infections, produces rapid improvements in lung function. A retrospective study of 29 patients treated with azithromycin for six months showed gains in airflow measures as well as visible improvement on HRCT scans, with shrinking of the characteristic nodular shadows and tree-in-bud pattern.4Europe PMC. The effects of azithromycin on patients with diffuse panbronchiolitis: a retrospective study of 29 cases The benefit is not because azithromycin is killing bacteria. Research suggests it works by dampening the immune response, specifically by suppressing overactive T cells and reducing inflammatory signaling molecules. One study found azithromycin inhibited T cell proliferation and promoted a regulated form of cell death in those overactive immune cells through a specific signaling pathway.5PubMed Central. Azithromycin treats diffuse panbronchiolitis by targeting T cells via inhibition of mTOR pathway
Treatment typically continues for months and sometimes years. Erythromycin, the original macrolide used in this setting, also works through similar immune-modulating effects but is less commonly prescribed today because azithromycin has a more convenient dosing schedule and fewer gastrointestinal side effects. The key point for patients is that the macrolide dose is deliberate: this is not a standard antibiotic course, and stopping early because you “feel better” risks relapse.
Constrictive (Obliterative) Bronchiolitis
Constrictive bronchiolitis, sometimes called obliterative bronchiolitis or bronchiolitis obliterans, is a more ominous form. The small airways become scarred and narrowed, progressively trapping air in the lungs. It shows up most often after lung or heart-lung transplantation, affecting roughly a third or more of transplant recipients within the first two years.6Lippincott Williams & Wilkins / PubMed Central. Constrictive (obliterative) bronchiolitis It also occurs after bone marrow transplantation, in people with rheumatoid arthritis, after inhalation of toxic chemicals like nitrogen dioxide or diacetyl (the flavoring chemical linked to “popcorn lung”), and after certain drug exposures.
Treatment is frustrating because the fibrotic scarring of the airways is largely irreversible. In the transplant setting, management focuses on adjusting immunosuppressive regimens, sometimes adding azithromycin for its anti-inflammatory effects, and optimizing supportive care. For occupational or toxic-fume causes, the most important intervention is removing the person from continued exposure as early as possible, because the damage worsens with each additional contact.7Elsevier. Early detection, clinical diagnosis, and management of lung disease from exposure to diacetyl Corticosteroids are often tried, but the response is inconsistent and the disease frequently progresses despite treatment. In severe cases, lung transplantation becomes the only remaining option, though it carries the cruel irony that constrictive bronchiolitis can recur in the transplanted lungs.
A systematic review of sporadic constrictive bronchiolitis cases found that pulmonary function tests tended not to improve significantly over time, and the overall mortality rate across combined case series was about 82 per 1,000 patient-years.8Elsevier / ScienceDirect. Sporadic Obliterative Bronchiolitis: Case Series and Systematic Review of the Literature That is a sobering number and underscores why early detection matters so much: once significant scarring has set in, the window to preserve lung function narrows quickly.
Organizing Pneumonia and the Corticosteroid Tightrope
Cryptogenic organizing pneumonia, once called bronchiolitis obliterans organizing pneumonia or BOOP, is confusingly named but behaves quite differently from constrictive bronchiolitis. Instead of scarring the airways shut, the inflammatory process fills the small airways and surrounding lung tissue with plugs of granulation tissue. The good news is that it usually responds well to corticosteroids. The bad news is that relapses are common, and getting off steroids without triggering one requires patience.
A systematic review found that about 28% of patients with organizing pneumonia relapsed at some point, and the rate was even higher, around 36%, among those treated with corticosteroids, because most relapses occurred during tapering or after steroids were stopped.9Elsevier PMC. Systematic Review of Systemic Corticosteroids for Treatment of Organizing Pneumonia A prospective Chinese cohort study found a similar relapse rate of about 21%, with the median time to relapse being 12 months. Importantly, nearly two-thirds of relapses happened after prednisone was fully discontinued, and another 29% occurred as the dose was tapered below 10 mg per day. Fewer than 10% of relapses occurred at higher doses.10PubMed Central. Characteristics, prognosis, and risk factors for relapse in patients with cryptogenic organizing pneumonia: A prospective cohort study in China
This pattern has led researchers to investigate minimum maintenance doses that might prevent relapse without subjecting patients to the long-term side effects of higher steroid doses, things like bone loss, weight gain, blood sugar disruption, and immune suppression. One study identified a prednisolone dose of 5 mg per day as a meaningful threshold: patients who maintained at least that dose had significantly longer relapse-free intervals compared to those tapered below it.11Elsevier. Minimal effective dose of maintenance steroid therapy for relapse of cryptogenic organizing pneumonia That finding does not apply to every patient, but it gives clinicians a practical anchor when deciding how low to push the taper in someone who has already relapsed once.
The reassuring aspect of organizing pneumonia is that relapses generally respond to restarting or increasing corticosteroids. Unlike constrictive bronchiolitis, where structural damage accumulates, organizing pneumonia tends not to leave permanent scarring, and most patients eventually reach a stable state.
Smoking-Related Bronchiolitis
Respiratory bronchiolitis is almost universal among current smokers, usually as a subtle finding on imaging that causes few symptoms. In some people it progresses to respiratory bronchiolitis-interstitial lung disease, where the inflammation spills beyond the small airways into the surrounding lung tissue, causing breathlessness and cough. The treatment here is straightforward in principle but difficult in practice: stop smoking.
A long-term follow-up study found that physiologic improvement was limited to patients who quit smoking, and that corticosteroids or other immunosuppressive drugs had little effect on symptoms or lung function.12Chest. Respiratory bronchiolitis-interstitial lung disease: long-term outcome That makes smoking-related bronchiolitis one of the clearest cases where the treatment is entirely about removing the cause. No amount of medication compensates for continued exposure. Nicotine replacement, prescription cessation aids, and behavioral support all play a role in helping patients actually achieve and sustain abstinence, which is often the hardest part of the treatment plan.
Patients with smoking-related bronchiolitis who do quit may not see dramatic improvements on imaging immediately. The inflammatory changes can be slow to resolve, and some architectural distortion may persist. But lung function stabilization after cessation is the realistic goal, and for most people who quit, the disease does not progress further.
Autoimmune-Related Bronchiolitis
Rheumatoid arthritis is the autoimmune condition most frequently linked to bronchiolitis in adults, though Sjögren’s syndrome, systemic lupus, and other connective tissue diseases can also affect the small airways. The bronchiolitis in these patients can take several forms, including follicular bronchiolitis, where lymphoid tissue accumulates around the airways, and constrictive bronchiolitis, where the familiar scarring pattern develops.
Treatment involves immunosuppressive therapy tailored to the specific pattern of disease. For follicular bronchiolitis related to rheumatoid arthritis, oral corticosteroids at moderate to high doses have been used as the primary approach, sometimes combined with cyclophosphamide or biologic agents like etanercept.13European Respiratory Review. Bronchiolar disorders in systemic autoimmune rheumatic diseases The constrictive form, unfortunately, responds as poorly to treatment in the autoimmune setting as it does in other contexts. Managing the underlying rheumatoid arthritis aggressively can sometimes slow progression, but once fibrotic narrowing has taken hold, reversing it remains elusive.
An important clinical wrinkle is that some medications used to treat rheumatoid arthritis can themselves trigger bronchiolitis. Penicillamine, a drug now rarely prescribed, was historically one of the recognized culprits.6Lippincott Williams & Wilkins / PubMed Central. Constrictive (obliterative) bronchiolitis When a patient with rheumatoid arthritis develops new respiratory symptoms, clinicians need to sort out whether the lungs are being attacked by the disease or by the treatment, because the management differs accordingly.
The Role of Pulmonary Rehabilitation
Regardless of the subtype, adults with bronchiolitis who develop persistent breathlessness or exercise limitation benefit from pulmonary rehabilitation. Pulmonary rehab combines supervised exercise training, breathing techniques, and education. It does not reverse the underlying airway disease, but it improves exercise tolerance, reduces the sensation of breathlessness, and helps people function better in daily life. The American Thoracic Society recommends pulmonary rehabilitation for adults with chronic respiratory disease, and bronchiolitis patients with lasting functional impairment fit squarely within that recommendation.14American Journal of Respiratory and Critical Care Medicine. Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline
Supplemental oxygen, when needed, is another supportive measure that cuts across subtypes. Some patients with constrictive bronchiolitis or advanced diffuse panbronchiolitis develop chronically low oxygen levels, particularly during exertion. Oxygen therapy does not treat the disease, but it prevents the downstream consequences of low oxygen on the heart and other organs. Monitoring with periodic spirometry and oxygen saturation checks helps clinicians catch declines early enough to adjust the treatment strategy.
Occupational and Environmental Exposures
Some of the most preventable cases of adult bronchiolitis stem from workplace or environmental exposures. Diacetyl, the butter-flavoring chemical responsible for “popcorn lung” in microwave popcorn factory workers, is the most publicized example, but nitrogen dioxide, sulfur dioxide, ammonia, and other inhaled irritants can cause the same constrictive pattern. More recently, certain flavoring chemicals in e-cigarette liquids have raised concerns, though the evidence there is still developing.
For exposure-related bronchiolitis, early recognition and removal from the offending environment are the most important interventions.7Elsevier. Early detection, clinical diagnosis, and management of lung disease from exposure to diacetyl Workers in industries with known airway-toxic chemicals should have baseline and periodic spirometry monitoring. If airflow begins to decline, the exposure must stop before irreversible scarring develops. Once constrictive bronchiolitis from occupational exposure is established, the treatment options are the same limited set described above: supportive care, possible trial of anti-inflammatory medications, and in the worst cases, transplant evaluation.
Filing for workers’ compensation or disability benefits is a practical reality for many of these patients, and thorough documentation of the exposure history, pulmonary function trends, and imaging findings from the beginning of symptoms is important for those claims. Patients should keep their own copies of all test results.
When Adults Get RSV Bronchiolitis
RSV is not just a pediatric problem. Older adults, particularly those over 65 or with chronic lung or heart disease, can develop serious lower respiratory tract infections from RSV that include bronchiolitis. The clinical picture can resemble a COPD exacerbation or pneumonia, and RSV is often not tested for in adults, meaning cases go underdiagnosed. Treatment is supportive, following the same principles as other acute infectious bronchiolitis: fluids, oxygen as needed, and monitoring for respiratory deterioration.3Karger. Bronchiolitis in Adults: Etiology, Diagnostic, and Therapeutic Approach RSV vaccines for adults aged 60 and older are now available in several countries, adding a preventive dimension that did not exist a few years ago. For immunocompromised adults with RSV, ribavirin may be considered, though the evidence of benefit is strongest in patients with blood cancers.
The broader lesson from RSV in adults applies to adult bronchiolitis as a whole: the condition is underrecognized, often lumped in with more familiar diagnoses, and treated empirically with medications that may not help. Adults with persistent cough, wheeze, or unexplained breathlessness that does not respond to standard asthma or COPD treatment should ask about HRCT imaging and consider whether a bronchiolitis subtype might explain their symptoms.